These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16504915)

  • 21. [Indications and mechanisms of action of the intravenous immunoglobulines in the systemic autoimmune and inflammatory pathologies].
    Mouthon L; Bussone G; Kaveri S
    Rev Med Interne; 2009 Dec; 30(12 Suppl):H14-20. PubMed ID: 19995651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intravenous immunoglobulins (IgIV) in the treatment of autoimmune diseases and systemic inflammatory diseases].
    Kazatchkine M
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):209-10. PubMed ID: 8337128
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of IGIV in the treatment of immune-mediated dermatologic disorders.
    Gelfand EW
    J Investig Dermatol Symp Proc; 2004 Jan; 9(1):92-6. PubMed ID: 14870993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin.
    Ephrem A; Misra N; Hassan G; Dasgupta S; Delignat S; Duong Van Huyen JP; Chamat S; Prost F; Lacroix-Desmazes S; Kavery SV; Kazatchkine MD
    Clin Exp Med; 2005 Dec; 5(4):135-40. PubMed ID: 16362793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of immunomodulatory action of intravenous immunoglobulin in autoimmune and systemic inflammatory diseases.
    Vassilev T; Kazatchkine MD
    Ther Apher; 1997 Feb; 1(1):38-41. PubMed ID: 10225779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulin therapy for autoimmune diseases.
    Arnson Y; Shoenfeld Y; Amital H
    Autoimmunity; 2009 Sep; 42(6):553-60. PubMed ID: 19657774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.
    Orange JS; Hossny EM; Weiler CR; Ballow M; Berger M; Bonilla FA; Buckley R; Chinen J; El-Gamal Y; Mazer BD; Nelson RP; Patel DD; Secord E; Sorensen RU; Wasserman RL; Cunningham-Rundles C;
    J Allergy Clin Immunol; 2006 Apr; 117(4 Suppl):S525-53. PubMed ID: 16580469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.
    Bayry J; Thirion M; Misra N; Thorenoor N; Delignat S; Lacroix-Desmazes S; Bellon B; Kaveri S; Kazatchkine MD
    Neurol Sci; 2003 Oct; 24 Suppl 4():S217-21. PubMed ID: 14598046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
    Dalakas MC
    Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intravenous immunoglobulin therapy].
    Mouthon L
    Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunomodulation with intravenous immunoglobulin.
    Hall PD
    Pharmacotherapy; 1993; 13(6):564-73. PubMed ID: 8302679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.
    Bayry J; Misra N; Latry V; Prost F; Delignat S; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Clin Biol; 2003 Jun; 10(3):165-9. PubMed ID: 12798851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunomodulatory effects of intravenous immunoglobulins in autoimmune diseases].
    Mouthon L; Lacroix-Desmazes S; Pashov A; Kaveri SV; Kazatchkine MD
    Rev Med Interne; 1999; 20 Suppl 4():423s-430s. PubMed ID: 10522317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders.
    Ballow M
    J Allergy Clin Immunol; 2011 Feb; 127(2):315-23; quiz 324-5. PubMed ID: 21185071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intravenous immunoglobulins in hematologic therapy].
    Giovanelli E
    Clin Ter; 1992 Sep; 141(9 Pt 2):69-73. PubMed ID: 1468201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of intravenous immunoglobulin action in the treatment of autoimmune disorders.
    Larroche C; Chanseaud Y; Garcia de la Pena-Lefebvre P; Mouthon L
    BioDrugs; 2002; 16(1):47-55. PubMed ID: 11909001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of autoimmune disease: synergy between plasma exchange and intravenous immunoglobulins.
    Nydegger UE; Sturzenegger T
    Ther Apher; 2001 Jun; 5(3):186-92. PubMed ID: 11467755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inflammation and demyelinization: IgIV mode of action].
    Vallat JM; Magy L; Keita M
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 1():3S12-3S16. PubMed ID: 17075522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin.
    Jordan SC; Toyoda M
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):31-8. PubMed ID: 8033432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous immune globulins. A review of their uses in selected immunodeficiency and autoimmune diseases.
    Pirofsky B; Kinzey DM
    Drugs; 1992 Jan; 43(1):6-14. PubMed ID: 1372861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.